Skip to main content
Atezolizumab fails to improve outcomes in postsurgery kidney cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Atezolizumab fails to improve outcomes in postsurgery kidney cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Renal Cell Carcinoma
1
1
Cancer
0
0.9
Breast Cancer
0
0.89
Lung Cancer
0
0.89
Metastasis
0
0.86
Skin Cancer
0
0.84
Hepatocellular Carcinoma
0
0.8
Biologic Therapy
0
0.77
Immunotherapy
0
0.99
Kidney Cancer
0
0.98
Small Cell Lung Cancer
0
0.42
Targeted Cancer Therapy
0
0.37
Genomic Medicine
0
0.27
Toxicology
0
0.27
Biomarker
0
0.14
Kidney
0
0.14
Lung
0
0.14
Europe
0
0.09
Receptors
0
0.09
Surgery
0
0.09
Adjuvant Setting
0
0.04
Adjuvant Therapy
0
0.04
Breast
0
0.04
Clinical Guidelines
0
0.04
Disease Recurrence
0
0.04
Medical Oncology
0
0.04
Melanoma
0
0.04
Tissue
0
0.04
Transplant Evaluation
0
0.04
Tumor
0
0.04
Vascular Endothelial Growth Factor
0
0.04
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
0.9
Nephrology
0
1
General Surgery
0
0.8
Edit Tags